feed,title,long_url,short_url
MarketWatch,Pfizer's COVID antiviral cut hospitalizations or death by 89% in Phase 2/3 study,http://feeds.marketwatch.com/~r/marketwatch/bulletins/~3/EtUOO8HB4Y4/go,https://on.mktw.net/3mJnPOe
